Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas

[1]  M. Weller,et al.  Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. , 2015, Neuro-oncology.

[2]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[3]  K. Aldape,et al.  A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[4]  P. Wen,et al.  Current status of antiangiogenic therapies for glioblastomas , 2014, Expert opinion on investigational drugs.

[5]  Walter J Curran,et al.  Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Maria Werner-Wasik,et al.  Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Susan M. Chang,et al.  Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. , 2013, The Lancet. Oncology.

[8]  Susan M. Chang,et al.  Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L Junck,et al.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. , 2011, The Lancet. Oncology.

[10]  M. Prados,et al.  Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept , 2011, Clinical Cancer Research.

[11]  P. Wen,et al.  Response Assessment in Neuro-Oncology , 2011, Current oncology reports.

[12]  K. Hopkins,et al.  Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. Mikkelsen,et al.  Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Tracy T Batchelor,et al.  Angiogenesis as a therapeutic target in malignant gliomas. , 2009, The oncologist.

[15]  John A Butman,et al.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Yancopoulos,et al.  VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. , 2007, International journal of radiation oncology, biology, physics.

[17]  Lei Xu,et al.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[18]  T. Tombaugh.  Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[19]  J. Becker,et al.  Normative Data for Determining Significance of Test–Retest Differences on Eight Common Neuropsychological Instruments , 2004, The Clinical neuropsychologist.

[20]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability. , 1998 .

[21]  H. Levin,et al.  Benton Controlled Oral Word Association Test: reliability and updated norms. , 1996, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.